These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12004340)

  • 1. Hepatic steatosis and its relationship to transplantation.
    Imber CJ; St Peter SD; Handa A; Friend PJ
    Liver Transpl; 2002 May; 8(5):415-23. PubMed ID: 12004340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impairment of hepatic microcirculation in fatty liver.
    Ijaz S; Yang W; Winslet MC; Seifalian AM
    Microcirculation; 2003 Dec; 10(6):447-56. PubMed ID: 14745457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty liver and liver transplantation.
    Koehler E; Watt K; Charlton M
    Clin Liver Dis; 2009 Nov; 13(4):621-30. PubMed ID: 19818309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of steatotic graft in living-donor liver transplantation.
    Soejima Y; Shimada M; Suehiro T; Kishikawa K; Yoshizumi T; Hashimoto K; Minagawa R; Hiroshige S; Terashi T; Ninomiya M; Shiotani S; Harada N; Sugimachi K
    Transplantation; 2003 Jul; 76(2):344-8. PubMed ID: 12883190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saying "Yes" to obese living liver donors: short-term intensive treatment for donors with hepatic steatosis in living-donor liver transplantation.
    Perkins JD
    Liver Transpl; 2006 Jun; 12(6):1012-3. PubMed ID: 16721781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic steatohepatitis in donors for living donor liver transplantation.
    Yamamoto K; Takada Y; Fujimoto Y; Haga H; Oike F; Kobayashi N; Tanaka K
    Transplantation; 2007 Feb; 83(3):257-62. PubMed ID: 17297396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation.
    Ryan CK; Johnson LA; Germin BI; Marcos A
    Liver Transpl; 2002 Dec; 8(12):1114-22. PubMed ID: 12474149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steatotic liver transplantation in the mouse: a model of primary nonfunction.
    Birsner JH; Wan C; Cheng G; Evans ZP; Polito CC; Fiorini RN; Gilbert G; Haines JK; Schmidt MG; Chavin KD
    J Surg Res; 2004 Jul; 120(1):97-101. PubMed ID: 15172195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Living donor liver transplantation: histological abnormalities found on liver biopsies of apparently healthy potential donors.
    Tran TT; Changsri C; Shackleton CR; Poordad FF; Nissen NN; Colquhoun S; Geller SA; Vierling JM; Martin P
    J Gastroenterol Hepatol; 2006 Feb; 21(2):381-3. PubMed ID: 16509862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Auxiliary partial orthotopic living donor liver transplantation in a patient with alcoholic liver cirrhosis to overcome donor steatosis.
    Cho JY; Suh KS; Kwon CH; Yi NJ; Kim MA; Jang JJ; Minn KW; Lee KU
    Transpl Int; 2006 May; 19(5):424-9. PubMed ID: 16623878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonalcoholic fatty liver disease: is all the fat bad?
    Clouston AD; Powell EE
    Intern Med J; 2004 Apr; 34(4):187-91. PubMed ID: 15086699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertension and fatty liver: guilty by association?
    Brookes MJ; Cooper BT
    J Hum Hypertens; 2007 Apr; 21(4):264-70. PubMed ID: 17273155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic microcirculation in fatty liver disease.
    Farrell GC; Teoh NC; McCuskey RS
    Anat Rec (Hoboken); 2008 Jun; 291(6):684-92. PubMed ID: 18484615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-alcoholic steatohepatitis in children.
    Nanda K
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation.
    Verran D; Kusyk T; Painter D; Fisher J; Koorey D; Strasser S; Stewart G; McCaughan G
    Liver Transpl; 2003 May; 9(5):500-5. PubMed ID: 12740794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center.
    Lee JY; Kim KM; Lee SG; Yu E; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
    J Hepatol; 2007 Aug; 47(2):239-44. PubMed ID: 17400323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Living-donor liver transplantation: evaluation of donor and recipient.
    Sauer P; Schemmer P; Uhl W; Encke J
    Nephrol Dial Transplant; 2004 Jul; 19 Suppl 4():iv11-5. PubMed ID: 15240843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.
    Burra P; Loreno M; Russo FP; Germani G; Galligioni A; Senzolo M; Cillo U; Zanus G; Fagiuoli S; Rugge M
    Liver Transpl; 2009 Jun; 15(6):619-28. PubMed ID: 19479805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allograft steatohepatitis in progressive familial intrahepatic cholestasis type 1 after living donor liver transplantation.
    Miyagawa-Hayashino A; Egawa H; Yorifuji T; Hasegawa M; Haga H; Tsuruyama T; Wen MC; Sumazaki R; Manabe T; Uemoto S
    Liver Transpl; 2009 Jun; 15(6):610-8. PubMed ID: 19479804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rapid and reliable means of assessing hepatic steatosis in vivo via electrical bioimpedance.
    Hessheimer AJ; Parramón D; Guimerà A; Erill I; Rimola A; García-Valdecasas JC; Villa R; Fondevila C
    Transplantation; 2009 Sep; 88(5):716-22. PubMed ID: 19741471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.